Cited by 477Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Parkin-deficient mice are not a robust model of parkinsonism

Open access

Perez, Francisco A., Palmiter, Richard D.·2005·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0409598102PMC PMC548311

Open this paper in CoChat — free account

Abstract

Mutations in the human parkin gene cause autosomal recessive juvenile parkinsonism, a heritable form of Parkinson's disease (PD). To determine whether mutations in the mouse parkin gene ( Park2 ) also result in a parkinsonian phenotype, we generated mice with a targeted deletion of parkin exon 2. Using an extensive behavioral screen, we evaluated neurological function, motor ability, emotionality, learning, and memory in aged Parkin-deficient mice. The behavioral profile of Parkin-deficient mice on a B6;129S4 genetic background was strikingly similar to that of control mice, and most differences were not reproducible by using coisogenic mice on a 129S4 genetic background. Moreover, catecholamine levels in the striatum, olfactory bulb, and spinal cord of Parkin-deficient mice were normal. In contrast to previous studies using independently generated Parkin-deficient mice, we found no evidence for nigrostriatal, cognitive, or noradrenergic dysfunction. Understanding why Parkin-deficient mice do not exhibit robust signs of parkinsonism could advance knowledge and treatment of PD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.0409598102

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Controlling the false discovery rate in behavior genetics research
Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N., & Golani, I. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00297-2 · Cited by 4,146
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Parkin functions as an E2-dependent ubiquitin– protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308947200 · Cited by 913
Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?
Gerlai, R. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)20020-7 · Cited by 881
Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment
Rogers, D. C., Fisher, E. M. C., Brown, S. D. M., Peters, J., Hunter, A. J., & Martin, J. E. (1997) · Mammalian Genome · doi:10.1007/s003359900551 · Cited by 795
Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity
Imai, Y., Soda, M., & Takahashi, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000447200 · Cited by 766
Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice
Simpson, E. M., Linder, C. C., Sargent, E. E., Davisson, M. T., Mobraaten, L. E., & Sharp, J. J. (1997) · Nature Genetics · doi:10.1038/ng0597-19 · Cited by 684

Show all 45 references

Research works printed but not linked: 3

Schrag, A. (2004) J. Neurol. 251, 795-804.15258780
Ralph, R. J., Paulus, M. P. & Geyer, M. A. (2001) J. Pharmacol. Exp. Ther. 298, 148-155.11408536
Flaherty, L. (1981) in The Mouse in Biomedical Research, eds. Foster, H. L., Small, J. D. & Fox, J. G. (Academic, New York), Vol. 1, pp. 215-222.

Sorted by citations

Items 301–400 of 475

Overinhibition of corticostriatal activity following prenatal cocaine exposure
Wang, W., Niţulescu, I., Lewis, J. S., Lemos, J. C., Bamford, I. J., Posielski, N. M., Storey, G. P., Phillips, P. E. M., & Bamford, N. S. (2012) · Annals of Neurology · doi:10.1002/ana.23805 · Cited by 19
Midbrain neuronal cultures from parkin mutant mice are resistant to nitric oxide-induced toxicity
Solano, R. M., Menéndez, J., Casarejos, M. J., Rodríguez‐Navarro, J. A., de Yébenes, J. G., & Mena, M. A. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.027 · Cited by 19
Literature-Related Discovery (LRD)
Kostoff, R. N., Block, J. A., Solka, J. L., Briggs, M. B., Rushenberg, R. L., Stump, J. A., Johnson, D., Lyons, T. J., & Wyatt, J. R. (2007) · Defense Technical Information Center (DTIC) · doi:10.21236/ada473438 · Cited by 19
Autophagy in the mammalian nervous system: a primer for neuroscientists
Suomi, F., & McWilliams, T. G. (2019) · Neuronal Signaling · doi:10.1042/ns20180134 · Cited by 18
Parkin in the regulation of fat uptake and mitochondrial biology
Kim, K., & Sack, M. N. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328352dc5d · Cited by 18
Modeling sporadic Parkinson's disease by silencing the ubiquitin E3 ligase component, SKP1A
Mandel, S. A., Fishman-Jacob, T., & Youdim, M. B. H. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70803-x · Cited by 18
PARKIN is not required to sustain OXPHOS function in adult mammalian tissues
Filograna, R., Gerlach, J., Choi, H.-N., Rigoni, G., Barbaro, M., Oscarson, M., Lee, S., Tiklová, K., Ringnér, M., Koolmeister, C., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00707-0 · Cited by 17
Reduced intestinal lipid absorption and body weight-independent improvements in insulin sensitivity in high-fat diet-fed Park2 knockout mice
Costa, D. K., Huckestein, B. R., Edmunds, L. R., Petersen, M. C., Nasiri, A. R., Butrico, G. M., Abulizi, A., Harmon, D. B., Lu, C., Mantell, B. S., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00042.2016 · Cited by 17
Characterization of Dopaminergic System in the Striatum of Young Adult Park2−/− Knockout Rats
Gemechu, J. M., SHARMA, A. K., Yu, D., Xie, Y., Merkel, O. M., & Moszczyńska, A. (2018) · Scientific Reports · doi:10.1038/s41598-017-18526-0 · Cited by 17
Cilostazol Mediates Immune Responses and Affects Angiogenesis During the Acute Phase of Hind Limb Ischemia in a Mouse Model
Paronis, E., Katsimpoulas, M., Kadoglou, N. P. E., Provost, C., Stasinopoulou, M., Spyropoulos, C., Poulaki, E., Prignon, A., Kakisis, I., Kostomitsopoulos, N. G., et al. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248419897852 · Cited by 17
Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson’s disease
Kostrzewa, R. M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02479-4 · Cited by 17
The compartmentalised nature of neuronal mitophagy: molecular insights and implications
Borbolis, F., & Palikaras, K. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.31 · Cited by 16
The effects of parkin suppression on the behaviour, amyloid processing, and cell survival in APP mutant transgenic mice
Perucho, J., Casarejos, M. J., Rubio, I., Rodríguez‐Navarro, J. A., Gómez, A., Ampuero, I., Rodal, I., Solano, R. M., Carro, E., de Yébenes, J. G., et al. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.029 · Cited by 16
The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson’s Disease
Kumar, S., Mattern, M. R., Goldberg, M. S., & Butt, T. R. (2023) · NeuroMolecular Medicine · doi:10.1007/s12017-023-08738-1 · Cited by 16
Combined QTL and Selective Sweep Mappings with Coding SNP Annotation andcis-eQTL Analysis RevealedPARK2andJAG2as New Candidate Genes for Adiposity Regulation
Roux, P., Boitard, S., Blum, Y., Parks, B. W., Montagner, A., Mouisel, É., Djari, A., Esquerré, D., Désert, C., Boutin, M., et al. (2015) · G3 Genes Genomes Genetics · doi:10.1534/g3.115.016865 · Cited by 16
Parkin coregulates glutathione metabolism in adult mammalian brain
Kodsi, D. N. E., Tokarew, J. M., Sengupta, R., Lengacher, N. A., Chatterji, A., Nguyen, A., Boston, H., Jiang, Q., Palmberg, C., Pileggi, C. A., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01488-4 · Cited by 15
Construct, Face, and Predictive Validity of Parkinson’s Disease Rodent Models
Guimarães, R. P., de Resende, M. C. S., Tavares, M. M., de Azevedo, C. V. I. B., Ruiz, M. C. M., & Mortari, M. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168971 · Cited by 18
A call for clinically driven experimental design in assessing neuroprotection in experimental Parkinsonism
Bézard, E. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00003 · Cited by 15
Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease
Kim, J. J., Daadi, E. W., Oh, T. T., Daadi, E. S., & Daadi, M. M. (2022) · Genes · doi:10.3390/genes13111937 · Cited by 14
Behavioral testing regimens in genetic-based animal models of Parkinson's disease: Cogencies and caveats
Bury, A. G., & Pienaar, I. S. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.007 · Cited by 14
Diminution of eIF4E activity suppresses parkin mutant phenotypes
Ottone, C., Galasso, A., Gemei, M., Pisa, V., Gigliotti, S., Piccioni, F., Graziani, F., & Verrotti, A. C. (2010) · Gene · doi:10.1016/j.gene.2010.09.003 · Cited by 15
The Role of Protein S-Nitrosylation in Protein Misfolding-Associated Diseases
Ju, Y.-J., Lee, H.-W., Choi, J.-W., & Choi, M.-S. (2021) · Life · doi:10.3390/life11070705 · Cited by 14
Aging, Parkinson’s Disease, and Models: What Are the Challenges?
Bellantuono, I., Mortiboys, H., Rocha, E. M., Chamoli, M., Chinta, S. J., Andersen, J. K., Wallis, R., Bézard, E., Goldberg, M., Greenamyre, T., et al. (2023) · doi:10.59368/agingbio.20230010 · Cited by 13
Preserved striatal innervation maintains motor function despite severe loss of nigral dopaminergic neurons
Paß, T., Ricke, K. M., Hofmann, P., Chowdhury, R., Nie, Y., Chinnery, P. F., Endepols, H., Neumaier, B., Carvalho, A. F., Rigoux, L., et al. (2024) · Brain · doi:10.1093/brain/awae089 · Cited by 14
Diverse Functions of Parkin in Midbrain Dopaminergic Neurons
Song, P., & Krainc, D. (2024) · Movement Disorders · doi:10.1002/mds.29890 · Cited by 13
Can parkin be a target for future treatment of Parkinson's disease?
Kubo, S., Hatano, T., Takanashi, M., & Hattori, N. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.827173 · Cited by 13
Animal Models of Autosomal Recessive Parkinsonism
Bastioli, G., Regoni, M., Cazzaniga, F. A., Luca, C. M. G. D., Bistaffa, E., Zanetti, L., Moda, F., Valtorta, F., & Sassone, J. (2021) · Biomedicines · doi:10.3390/biomedicines9070812 · Cited by 13
The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases
Klonarakis, M., Vos, M. D., Woo, E. K., Ralph, L. T., Thacker, J. S., & Gil‐Mohapel, J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104541 · Cited by 14
Early Dyskinesias in Parkinson’s Disease Patients With Parkin Mutation: A Primary Corticostriatal Synaptopathy?
Sassone, J., Valtorta, F., & Ciammola, A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00273 · Cited by 13
CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology
Liao, S.-C., Kano, K., Phanse, S., Nguyen, M. K., Margolis, E. B., Fu, Y., Meng, J. X., Moutaoufik, M. T., Chatterton, Z., Saccon, T. D., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu0726 · Cited by 12
Age related immune modulation of experimental autoimmune encephalomyelitis in PINK1 knockout mice
Cossu, D., Yokoyama, K., Sato, S., Noda, S., Sakanishi, T., Sechi, L. A., & Hattori, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1036680 · Cited by 12
Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method
Bılgıç, B., Bayram, A., Arslan, A. B., Hanagasi, H. A., Dursun, B., Gurvit, H. I., Emre, M., & Lohmann, E. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.02.017 · Cited by 12
Mechanisms of mitophagy: putting the powerhouse into the doghouse
Riley, J. S., & Tait, S. W. G. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0137 · Cited by 13
The Role of Neuroinflammation in Parkinson's Disease
Chen, X., & Tansey, M. G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384913-7.00018-6 · Cited by 12
Human mini-brains for reconstituting central nervous system disorders
Kang, Y. J., Xue, Y., Shin, J. H., & Cho, H. (2023) · Lab on a Chip · doi:10.1039/d2lc00897a · Cited by 11
Homozygous CADPS2 Mutations Cause Neurodegenerative Disease with Lewy Body‐like Pathology in Parrots
Lorenzo‐Betancor, O., Galosi, L., Bonfili, L., Eleuteri, A. M., Cecarini, V., Verin, R., Dini, F., Attili, A., Berardi, S., Biagini, L., et al. (2022) · Movement Disorders · doi:10.1002/mds.29211 · Cited by 10
Autophagy inhibition rescues structural and functional defects caused by the loss of mitochondrial chaperone Hsc70-5 in Drosophila
Zhu, J., Hannan, S. B., Dräger, N. M., Vereshchagina, N., Krahl, A.-C., Fu, Y., Elliott, C. J. H., Han, Z., Jahn, T. R., & Rasse, T. M. (2021) · Autophagy · doi:10.1080/15548627.2020.1871211 · Cited by 10
Lack of association between cancer history and PARKIN genotype: A family based study in PARKIN/Parkinson's Families
Alcalay, R. N., Clark, L. N., Marder, K. S., & Bradley, W. E. C. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.21995 · Cited by 10
Structural studies of parkin and sacsin: Mitochondrial dynamics in neurodegenerative diseases
Li, X., & Gehring, K. (2015) · Movement Disorders · doi:10.1002/mds.26357 · Cited by 12
Physiology versus pathology in Parkinson's disease
Nakamura, K., & Edwards, R. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704254104 · Cited by 10
Data mining in a behavioral test detects early symptoms in a model of amyotrophic lateral sclerosis.
Kafkafi, N., Yekutieli, D., Yarowsky, P., & Elmer, G. I. (2008) · Behavioral Neuroscience · doi:10.1037/0735-7044.122.4.777 · Cited by 10
Progress in Parkinson's disease animal models of genetic defects: Characteristics and application
Zhang, C., Chen, S., Li, X., Xu, Q., Lin, Y., Lin, F., Yuan, M., Zi, Y., & Cai, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113768 · Cited by 9
Of Parkin and Parkinson's: light and dark sides of a multifaceted E3 ubiquitin–protein ligase
Corti, O., & Brice, A. (2007) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2007.11.002 · Cited by 9
BAC to Degeneration
Lu, X. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)89002-8 · Cited by 10
Presynapses are mitophagy pit stops that prevent axon degenerationPreprint
Lam, W. K., Lindblom, R. S. J., Milky, B., Mazzachi, P., Hadian-Jazi, M., Küng, C. J., Khuu, G., Uoselis, L., Nguyen, T. N., Skulsuppaisarn, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.09.611943 · Cited by 10
SARM1 loss protects retinal ganglion cells in a mouse model of autosomal dominant optic atrophy
Ding, C., Ndiaye, P. S., Campbell, S. R., Fry, M. Y., Gong, J., Wienbar, S. R., Gibbs, W., Morquette, P., Chao, L. H., Do, M. T. H., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191315 · Cited by 8
PINK1 Deficiency Facilitates Palmitic Acid‐Induced Inflammation by Disrupting Mitochondrial Function to Activate mtDNA‐cGAS‐STING Signaling
Ye, B., Pei, Y., Li, H., Jiang, Y., Jin, W., Gao, Y., Liu, W., Guan, X., Qiao, Y., Gao, X., et al. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70092 · Cited by 8
Translating Pathological Brain Activity Primers in Parkinson’s Disease Research
Mîrzac, D., Kreis, S. L., Luhmann, H. J., González‐Escamilla, G., & Groppa, S. (2023) · Research · doi:10.34133/research.0183 · Cited by 8
Role of Astrogliosis in the Pathogenesis of Parkinson’s Disease: Insights into Astrocytic Nrf2 Pathway as a Potential Therapeutic Target
Bhushan, B., & Singh, N. K. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273270473231002104610 · Cited by 8
Patient heal thyself: modeling and treating neurological disorders using patient-derived stem cells
Ess, K. C. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213480713 · Cited by 8
Pathogenic insights to Parkin-linked model mice
Sato, S., Noda, S., & Hattori, N. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.03.014 · Cited by 8
Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s disease
Hollville, É., Joers, V. L., Nakamura, A., Swahari, V., Tansey, M. G., Moy, S. S., & Deshmukh, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-73854-y · Cited by 10
Developmental Coordination Disorder in a Patient with Mental Disability and a Mild Phenotype Carrying Terminal 6q26-qter Deletion
Cinque, M. D., Palumbo, O., Mazzucco, E., Simone, A., Palumbo, P., Ciavatta, R., Maria, G., Ferese, R., Gambardella, S., Angiolillo, A., et al. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00206 · Cited by 8
Enhanced dense core granule function and adrenal hypersecretion in a mouse model of Rett syndrome
Ladas, T. P., Chan, S., Ogier, M., Smith, C. L., & Katz, D. M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06858.x · Cited by 8
Parkin-deficient rats are resistant to neurotoxicity of chronic high-dose methamphetamine
SHARMA, A. K., Bazylianska, V., & Moszczyńska, A. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113811 · Cited by 7
Loss of parkin causes endoplasmic reticulum calcium dyshomeostasis by upregulation of reticulocalbin 1
Rybarski, M. O., Mrohs, D., Osenberg, K., Hemmersbach, M., Pfeffel, K., Steinkamp, J., Schmidt, D., Violou, K., Schäning, R., Schmidtke, K., et al. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15917 · Cited by 7
Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse model
Greenbaum, L., Lifschytz, T., Zozulinsky, P., Broner, E. C., Slonimsky, A., Kohn, Y., & Lerer, B. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.006 · Cited by 7
Molecular Pathogenesis, Experimental Models and New Therapeutic Strategies for Parkinson‘s Disease
Yamashita, H., & Matsumoto, M. (2007) · Regenerative Medicine · doi:10.2217/17460751.2.4.447 · Cited by 7
Current and Emerging MR Methods and Outcome in Rodent Models of Parkinson’s Disease: A Review
Petiet, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.583678 · Cited by 6
Dopamine neuron dysfunction and loss in the PrknR275W mouse model of juvenile parkinsonism
Regoni, M., Zanetti, L., Sevegnani, M., Domenicale, C., Magnabosco, S., Patel, J. C., Fernandes, M. K., Feeley, R. M., Monzani, E., Mini, C., et al. (2024) · Brain · doi:10.1093/brain/awae276 · Cited by 6
Parkinson’s Disease and Parkin: Insights from Park2 Knockout Mice
Stephenson, S. E. M., Juliet, M., & Paul, J. (2012) · InTech eBooks · doi:10.5772/18148 · Cited by 6
Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse
Regoni, M., Zanetti, L., Comai, S., Mercatelli, D., Novello, S., Albanese, F., Croci, L., Consalez, G. G., Ciammola, A., Valtorta, F., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9050514 · Cited by 6
Parkin Maintains Robust Pacemaking in Human Induced Pluripotent Stem Cell‐Derived A9 Dopaminergic Neurons
Pu, J., Lin, L., Jiang, H., Hu, Z., Li, H., Yan, Z., Zhang, B., & Feng, J. (2023) · Movement Disorders · doi:10.1002/mds.29434 · Cited by 6
Interactions between genetic variants and dietary lipid composition: effects on circulating LDL cholesterol in children
Ahola‐Olli, A., Pitkänen, N., Kettunen, J., Oikonen, M., Mikkilä, V., Lehtimäki, T. J., Kähönen, M. A. P., Pahkala, K., Niinikoski, H., Kangas, A. J., et al. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.085027 · Cited by 6
Quaking but not parkin is the major tumor suppressor in 6q deleted region in glioblastoma
Yasar, F. B. A., Shingu, T., Zamler, D. B., Zaman, M. F., Chien, D., Zhang, Q., Ren, J., & HU, J. L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.931387 · Cited by 6
Lack of direct role of parkin in the steady-state level and aggregation of α-synuclein and the clearance of pre-formed aggregates
Kim, Y. S., Patel, S. S., & Lee, S. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.024 · Cited by 6
Animal Models of Parkinson's Disease to Aid Drug Discovery and Development
Merchant, K., Chesselet, M.-F., Hu, S., & Fahn, S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00017-5 · Cited by 6
The Bac Transgenic Approach to Study Parkinson's Disease in Mice
Yang, X. W., & Lu, X. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00019-1 · Cited by 5
Modeling familial and sporadic Parkinson's disease in small fishes
Yamanaka, T., & Matsui, H. (2023) · Development Growth & Differentiation · doi:10.1111/dgd.12904 · Cited by 5
Mitochondrial DNA Instability Supersedes Parkin Mutations in Driving Mitochondrial Proteomic Alterations and Functional Deficits in Polg Mutator Mice
Trease, A. J., Totusek, S., Lichter, E. Z., Stauch, K. L., & Fox, H. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126441 · Cited by 5
Current concepts on the etiology and pathogenesis of Parkinson disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00005-6 · Cited by 5
Insights into PINK1/Parkin function and dysfunction from Drosophila models
Park, S., Kozhushko, N., Wight, T. H., & Whitworth, A. J. (2025) · Biochemical Journal · doi:10.1042/bcj20253459 · Cited by 5
PINK1: Multiple mechanisms of neuroprotection
Lizama, B. N., Otero, P. A., & Chu, C. T. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.08.003 · Cited by 4
Chapter 8 α-Synuclein and Synucleinopathies
Schlossmacher, M. G. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70059-0 · Cited by 4
Identification and characterization of a novel endogenous murine parkin mutation
Ramsey, C. P., & Giasson, B. I. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06605.x · Cited by 4
The Ubiquitin–Proteasome System in Parkinson's Disease
McNaught, K. S. P. (2007) · Wiley eBooks · doi:10.1002/9783527620234.ch8 · Cited by 4
Gastrodia elata Polysaccharide Ameliorates Parkinson’s Disease by Enhancing Dopamine Levels, Inhibiting NLRP3 Inflammasome Activation, and Promoting Mitochondrial Autophagy
Li, S., Li, M., Li, Y., Liang, S., Ling, L., Wang, H., & Guo, J. (2025) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x25500673 · Cited by 3
The emerging role and therapeutic targeting of autophagy-lysosome pathway in the pathogenesis of Parkinson’s disease
Shimizu, T., Isik, S., Kamath, N., & Yue, Z. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00555-3 · Cited by 3
Compensatory synaptotagmin-11 expression conceals parkinson’s disease-like phenotypes in parkin knockout mice
Dong, N., Xie, Z., Wei, A., Yang, Y., Deng, Y., Cheng, X., Wang, B., Chen, Y., Gu, Y., Yao, J., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02037-x · Cited by 3
Physiological and Behavioral Assessment of Tremor in Rodents
Salamone, J. D., Podurgiel, S. J., Collins‐Praino, L. E., & Correa, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00038-x · Cited by 3
EXPERIMENTAL ANIMAL MODELS OF PARKINSON’S DISEASE: AN OVERVIEW
Imran, M., Mishra, A., Usmani, A., & Eqbal, A. (2020) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2020.v13i11.39131 · Cited by 3
Electron Transport Chain
Aerts, L., & Morais, V. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00002-x · Cited by 3
Neuroprotection for Parkinson's Disease
Bézard, E. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00006-3 · Cited by 3
Mitophagy
King, L., & Plun‐Favreau, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00005-5 · Cited by 6
Genetic Modifiers of Neurological Disease
Kearney, J. A., & Jorge, B. S. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0023856 · Cited by 3
Ablation of Mitochondrial RCC1-L Induces Nigral Dopaminergic Neurodegeneration and Parkinsonian-like Motor SymptomsPreprint
Ellioff, K. J., Osting, S., Lentine, A., Welper, A. D., Bürger, C., & Greenspan, D. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.01.567409 · Cited by 3
MTFR1L is a cardiac antiaging factor for maintenance of mitochondrial homeostasis
Shi, L. P., Sun, Z., Cao, Y., Li, Y., Qing, W., Zhou, L., Xu, M., Mai, X., Ou, L., 杨小平, et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2527247123 · Cited by 3
A Non‐Mitophagy Activity of BNIP3L/NIX in Amygdala Glutamatergic Neurons is Essential for Contextual Fear Memory Formation
Zhang, X., Mo, X., Zhou, X., Liu, X., Li, G., Songhui, H., Lu, Y., Zhu, C., Feng, J., Chen, Z., et al. (2026) · Advanced Science · doi:10.1002/advs.202517585 · Cited by 2
The role of phospho-ubiquitin in mitochondrial health and diseases
Suresh, K., Rainville, C., Sterner, D. E., Goldberg, M. S., & Butt, T. R. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113128 · Cited by 3
A Systematic Review of Various In-vivo Screening Models as well as the Mechanisms Involved in Parkinson's Disease Screening Procedures
Wal, A., Wal, P., Vig, H., Samad, A., Khandai, M., & Tyagi, S. (2022) · Current Clinical Pharmacology · doi:10.2174/2772432817666220707101550 · Cited by 2
Mitophagy Responds to the Environmental Temperature and Regulates Mitochondrial Mass in Adipose Tissues
Yamashita, S.-I., & Kanki, T. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4584-5_16 · Cited by 2
Rodent Models of Autosomal Recessive Parkinson Disease
Gispert, S., Auburger, G. W. J., Kuruvilla, K. P., & LeDoux, M. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00019-6 · Cited by 2
Parkinson’s disease
Magen, I., & Chesselet, M. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.031 · Cited by 2
Effects of Parkin on the Mitochondrial Genome in the Heart and Brain of Mitochondrial Mutator Mice
Lichter, E. Z., Trease, A. J., Cooper, K. M., Stauch, K. L., & Fox, H. S. (2023) · Advanced Biology · doi:10.1002/adbi.202300154 · Cited by 2
Computer-aided Analysis of Selective Phytochemicals as Potent Inhibitors of Parkin: Major Biological Target of Parkinson’s disease
Nadia, A., Andleeb, S., Waqar, H., & Rasool, N. (2020) · Global Journal of Biotechnology and Biomaterial Science · doi:10.17352/gjbbs.000013 · Cited by 2
Mitochondrial biogenesis and mitophagy
Tan, S., Kennedy, B. K., & Wong, E. S. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821562-3.00037-x · Cited by 2
Evaluation of methods and applications for behavioural profiling of transgenic mice
Võikar, V. (2006) · Työväentutkimus Vuosikirja · Cited by 2
Role of mitophagy and mitochondria in aging and cellular senescence
Liang, X. F., Poulton, J., & Lechuga‐Vieco, A. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15260-3.00006-5 · Cited by 1
rAAV Fbxo7 gene therapy rescues the progressive nigrostriatal pathology in a mouse model of juvenile parkinsonism
Rawi, S. A., Tyers, P., Barker, R. A., & Laman, H. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02294-y · Cited by 1
Mitophagy in neuronal health and disease: from mechanisms to neurodegeneration
Basak, B., Riley, J. F., Nataraj, N. M., & Holzbaur, E. L. F. (2026) · Journal of Clinical Investigation · doi:10.1172/jci199847 · Cited by 1

Authors: Perez, F. A., & Palmiter, R. D.
Affiliations: Howard Hughes Medical Institute (US)
ORCID: Perez, Francisco A.
Palmiter, Richard D.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2005-01-31
Volume: 102
Issue: 6
Pages: 2174-2179
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0409598102
PMC: PMC548311
OpenAlex: W2129698492
Cited by: 477
References: 45
Citations by year: 2026: 6 · 2025: 9 · 2024: 18 · 2023: 18 · 2022: 31 · 2021: 33 · 2020: 29 · 2019: 18 · 2018: 24 · 2017: 18 · 2016: 19 · 2015: 17 · 2014: 26 · 2013: 21 · 2012: 27
FWCI: 19.69
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: Parkin, PARK2, juvenile parkinsonism, autosomal recessive juvenile parkinsonism, Parkinson's disease, exon 2 deletion, behavioral phenotypes, motor function, emotionality, learning and memory, catecholamine levels, noradrenergic dysfunction, genetic background effects, B6
MeSH terms: Amphetamines, Animals, Behavior, Animal, Disease Models, Animal, Emotions, Genotype, Humans, Learning, Memory, Mice, Inbred C57BL, Motor Activity, Nerve Tissue, Parkinson Disease, Phenotype, Mice, Knockout, Ubiquitin-Protein Ligases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Parkin-deficient mice are not a robust model of parkinsonism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks